首页   按字顺浏览 期刊浏览 卷期浏览 Dopamine and the kidney: a role in hypertension?
Dopamine and the kidney: a role in hypertension?

 

作者: Pedro Jose,   Gilbert Eisner,   Robin Felder,  

 

期刊: Current Opinion in Nephrology and Hypertension  (OVID Available online 2003)
卷期: Volume 12, issue 2  

页码: 189-194

 

ISSN:1062-4821

 

年代: 2003

 

出版商: OVID

 

关键词: angiotensin receptors;dopamine receptors;G protein-coupled receptor kinase;salt sensitivity

 

数据来源: OVID

 

摘要:

Purpose of reviewDefective transduction of the dopamine receptor signal in the kidney has been shown to be important in the pathogenesis of hypertension This review will discuss the genetic mechanism for the defective renal dopaminergic function and the interaction with other gene variant products in the pathogenesis of salt sensitivity and essential hypertension.Recent findingsSingle nucleotide polymorphisms of G protein-coupled receptor kinase type 4 (GRK4) phosphorylate, desensitize, and diminish the inhibitory action of D1receptors on sodium transport in the kidney. Inhibition of GRK4 expression normalizes renal proximal tubule D1receptor function in humans and rodents and ameliorates the hypertension in genetically hypertensive rats. Expression of the GRK4 variant, GRK4γA142V, produces hypertension and impairs the natriuretic effect of D1receptor stimulation in mice. In humans, GRK4 single nucleotide polymorphisms are associated with essential hypertension, particularly salt sensitive hypertension. The prediction of the hypertensive phenotype is most accurate when elements of the renin-angiotensin system and GRK4 are included in the analysis.SummaryGRK4 single nucleotide polymorphisms, by preventing the natriuretic function of the dopaminergic system and by allowing the antinatriuretic function of angiotensin II type 1 receptors to predominate, may be responsible for salt sensitivity. Hypertension develops with additional perturbations caused by the variants of other genes (e.g., α-adducin, angiotensin converting enzyme, angiotensinogen, angiotensin II type 1 receptor, aldosterone synthase, 11β-hydroxysteroid dehydrogenase type 2), the quantitative interaction of which may vary depending upon the genetic background.

 

点击下载:  PDF (90KB)



返 回